首页> 中文期刊>介入医学杂志 >Exogenous FGF-2 improves biological activity of endothelial progenitor cells exposed to high glucose conditions

Exogenous FGF-2 improves biological activity of endothelial progenitor cells exposed to high glucose conditions

     

摘要

Purpose: To investigate the effects of exogenous basic fibroblast growth factor-2(FGF-2) on the biological activity of endothelial progenitor cells(EPCs) exposed to high glucose conditions. Materials and Methods: 1) Bone marrow EPCs from C57BL/6 mice were isolated and cultured in vitro. EPC purity was identified by flow cytometry and immunofluorescence staining. 2) Apoptosis was detected by TUNEL assay. Migration and tube formation ability was detected by Transwell chamber and Matrigel assays, respectively. The expression and activation of β-catenin was detected by Western blot. 3) Doppler flowmetry was used to detect the effect of FGF2 on blood flow recovery in ischemic hind limbs of mice. Results: 1) FGF-2 treatment reversed high glucose induced growth inhibition of EPCs. FGF-2 treatment also increased migration and tube formation ability of EPCs even in high glucose conditions. 2) Western blot analysis demonstrated that the percentage of activated β-catenin/total β-catenin in the high glucose group were significantly lower than that in the control group, while FGF-2 treatment reversed high glucose induced β-catenin inhibition. 3) In vivo experiments demonstrated that the blood flow recovery in ischemic hind limbs of mice was significantly improved after FGF-2 treatment. Conclusion: Exogenous FGF-2 could play a role in the functional repair of damaged EPC exposed to high glucose conditions, via the activation of the Wnt/β-catenin signaling pathway.

著录项

  • 来源
    《介入医学杂志》|2018年第1期|P.9-14|共6页
  • 作者单位

    [1]Department of Interventional and Vascular surgery,Shanghai Tenth People''s Hospital,Tongji University,Shanghai 200072,China;

    [2]Institute of Intervention Radiology and Vascular Surgery,Tongji University,Shanghai 200072,China;

    [1]Department of Interventional and Vascular surgery,Shanghai Tenth People''s Hospital,Tongji University,Shanghai 200072,China;

    [2]Institute of Intervention Radiology and Vascular Surgery,Tongji University,Shanghai 200072,China;

    [1]Department of Interventional and Vascular surgery,Shanghai Tenth People''s Hospital,Tongji University,Shanghai 200072,China;

    [2]Institute of Intervention Radiology and Vascular Surgery,Tongji University,Shanghai 200072,China;

    [1]Department of Interventional and Vascular surgery,Shanghai Tenth People''s Hospital,Tongji University,Shanghai 200072,China;

    [2]Institute of Intervention Radiology and Vascular Surgery,Tongji University,Shanghai 200072,China;

    [1]Department of Interventional and Vascular surgery,Shanghai Tenth People''s Hospital,Tongji University,Shanghai 200072,China;

    [2]Institute of Intervention Radiology and Vascular Surgery,Tongji University,Shanghai 200072,China;

    [1]Department of Interventional and Vascular surgery,Shanghai Tenth People''s Hospital,Tongji University,Shanghai 200072,China;

    [2]Institute of Intervention Radiology and Vascular Surgery,Tongji University,Shanghai 200072,China;

    [1]Department of Interventional and Vascular surgery,Shanghai Tenth People''s Hospital,Tongji University,Shanghai 200072,China;

    [2]Institute of Intervention Radiology and Vascular Surgery,Tongji University,Shanghai 200072,China;

  • 原文格式 PDF
  • 正文语种 CHI
  • 中图分类 糖尿病性昏迷及其他并发症;
  • 关键词

    fibroblast growth factor-2; endothelial progenitor cells; angiogenesis; wnt/β-catenin signaling pathway; high glucose environment;

  • 入库时间 2023-07-26 02:23:40

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号